ASTEPRO 0.15% azelastine 188 mcg/actuation (as hydrochloride) nasal spray aerosol, pump actuated-metered dose

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

azelastine hydrochloride, Quantity: 0.206 mg/actuation

Disponible des:

Viatris Pty Ltd

Designació comuna internacional (DCI):

Azelastine hydrochloride

formulario farmacéutico:

Spray, nasal

Composición:

Excipient Ingredients: sucralose; benzalkonium chloride; hypromellose; sodium citrate dihydrate; purified water; disodium edetate; sorbitol solution (70 per cent) (crystallising)

Vía de administración:

Nasal

Unidades en paquete:

4 mL, 30 mL

tipo de receta:

(S2) Pharmacy Medicine

indicaciones terapéuticas:

For the symptomatic treatment of seasonal allergic rhinitis, perennial allergic rhinitis.

Resumen del producto:

Visual Identification: Clear, colourless solution filled into opaque high-density polyethylene (HDPE) bottles and fitted with screw-on metered-spray pump closures.; Container Type: Aerosol - Pump Actuated Metered Dose; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2013-12-11